Skip to Main Content

Paper Details

Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
Endocrinology
5
2020
-, 5-dihydrotestosterone, AKR1C3, AKR1C3 Aldo-keto Reductase, AR, CRPC, CRPC cells, DHEA, DHT, ERK1/2, FKBP5 mRNA, KO cells, PSA, Primary, Prostate Cancer, SNAI1, SULT2B, SULT2B KO cells, SULT2B-deficient prostate cancer, SULT2B-depleted CRPC cells, SULT2B-depleted cells, SULT2B-silenced cells, SULT2B1b, SULT2B1b Sulfotransferase, TWIST1, advanced prostate cancer, aldo, aldo-keto reductase (AKR)1C3, androgen, androgen receptor, castration-resistant prostate cancer, dehydroepiandrosterone, depleted cells, epithelial, hydroxysteroid, hydroxysteroid sulfotransferase, prostate-expressed, silenced cells, tumors
Author NameAffiliation
Alvin M MatsumotoEducation & Clinical Center
Colm MorrisseyUniversity of Washington
Yidong ChenUniversity of Texas Health San Antonio
Yidong ChenGreehy Children's Cancer Research Institute, University of Texas Health San Antonio
Elahe A MostaghelEducation & Clinical Center
Elahe A MostaghelFred Hutchinson Cancer Research Center
  • 1 - 6

Datasets

Release 1.2